Stockreport

Is Early AMX0114 Safety Data Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? [Yahoo! Finance]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF Amylyx Pharmaceuticals recently reported early Phase 1 LUMINA trial data for its ALS candidate AMX0114, showing no treatment-related serious adverse events in the first [Read more]